Profile
Herbert S.
Chow is the founder of Hemstat, Inc. Prior to founding Hemstat, he worked as the Chief Technology Officer at Stellar Biotechnologies, Inc. from 2012 to 2014.
Chow received his undergraduate degree from The Ohio State University and his doctorate from the University of Illinois.
Former positions of Herbert S. Chow
| Companies | Position | End |
|---|---|---|
Stellar Biotechnologies, Inc.
 Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded in 1999 and is headquartered in Port Hueneme, CA. | Chief Tech/Sci/R&D Officer | 2014-12-09 |
| Hemstat, Inc. | Founder | - |
Training of Herbert S. Chow
| The Ohio State University | Undergraduate Degree |
| University of Illinois | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Stellar Biotechnologies, Inc.
Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded in 1999 and is headquartered in Port Hueneme, CA. | Health Technology |
| Hemstat, Inc. |
- Stock Market
- Insiders
- Herbert S. Chow
